Changes in Tdap and MCV4 Vaccine Coverage Following Enactment of a Statewide Requirement of Tdap Vaccination for Entry Into Sixth Grade

Department of Pediatrics, College of Physicians and Surgeons, Mailman School of Public Health, Columbia University, 622 West 168th St, VC 402, New York, NY 10032, USA.
American Journal of Public Health (Impact Factor: 4.55). 09/2010; 100(9):1635-40. DOI: 10.2105/AJPH.2009.179341
Source: PubMed


We evaluated changes in tetanus toxoid, reduced diphtheria toxoid, acellular pertussis (Tdap), and tetravalen meningococcal (MCV4) vaccine coverage following enactment of a New York State mandate requiring Tdap before entering sixth grade.
Using data from a hospital-based immunization registry, we measured Tdap and MCV4 coverage among youths aged 11 to 14 years in New York City at 3 time points: premandate, mandate year 1, and mandate year 2.
Among overlapping cohorts of 4316 (premandate), 4131 (mandate year 1), and 3639 (mandate year 2) youths, Tdap coverage increased steadily over time (29%, 58%, and 83%, respectively). Increases were observed among all ages. Across the same time points, MCV4 coverage also increased (10%, 30%, and 60%, respectively). Most adolescents did not receive MCV4 during the same visit they received Tdap.
A Tdap school-entry mandate was associated with substantial increases in immunization coverage, even in age groups not directly affected by the mandate. At the postmandate time points, MCV4 coverage remained lower than Tdap coverage. Provider education should emphasize the importance of reviewing vaccine records and administering all recommended vaccines at every clinical encounter.

Download full-text


Available from: Vaughn I Rickert, Dec 18, 2013
  • Source
    • "Making vaccination mandatory can raise vaccination rates substantially (Averhoff et al., 2004; Kharbanda et al., 2010; Salmon et al., 2006; Abrevaya & Mulligan, 2011). However, Doyle et al. (2010b) found no correlation between meningitis vaccination rates and vaccination requires across U.S. states. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This chapter focuses on the marketing of preventive (prophylactic) vaccines. Preventive vaccines differ from therapeutic pharmaceuticals in a number of ways and pose distinctive marketing challenges. We first provide background information on the vaccine industry. We next analyze the main players carrying out the consumer, buyer and payer roles, and then move to a discussion of the key vaccine marketing decisions. We then summarize important trends, and conclude with a discussion of promising research questions.
    SSRN Electronic Journal 01/2012; DOI:10.2139/ssrn.1991709
  • Source
    • "In New York City Kharbanda et. al (Kharbanda et al., 2010) demonstrated that a 6 th grade school mandate for the tetanus-diphtheria-acellular pertussis (Tdap) vaccine was associated with a substantial increase in Tdap utilization among other, non-mandated adolescent age groups. However, adolescent utilization of the meningococcal vaccine (MCV4), which is targeted to adolescents but was not mandated at the time, did not increase at the same high rate in this study. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We sought to examine nationally the association between school mandates for adolescent tetanus-containing vaccines (Td and/or Tdap) and adolescent female human papillomavirus (HPV) vaccination. Each state was categorized by whether a school mandate for adolescent Td and/or Tdap vaccines was enacted. Mean HPV vaccine series initiation levels among adolescent females were compared between each mandate category. Mean HPV vaccine series initiation levels were significantly lower in states without Td/Tdap vaccine mandates than in those with mandates (42.9% vs. 47.3%; p=0.004). School mandates for adolescent Td/Tdap vaccination may have a carry-over effect on HPV vaccination.
    Preventive Medicine 12/2010; 52(3-4):268-9. DOI:10.1016/j.ypmed.2010.12.010 · 3.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To provide a clinically relevant synopsis of research findings regarding childhood and adolescent vaccines. Vaccine coverage is relatively static or improving for the vaccines included in the 2010 annual harmonized immunization schedules. Providers should be reviewing patients' immunization records at each visit to take advantage of any opportunity to administer indicated, age-appropriate vaccines. There have been infectious disease outbreaks among highly immunized populations, although unvaccinated or undervaccinated individuals continue to play large roles in the spread of disease. Infants, many of whom are too young to be vaccinated, continue to bear a large disease burden, which underscores the importance of cocooning and, in some cases, vaccination of pregnant women. Influenza, measles, mumps, and rubella, varicella, hepatitis A, meningococcal conjugate, human papillomavirus, diphtheria and tetanus toxoids and acellular pertussis, and tetanus and diphtheria toxoids and acellular pertussis vaccines are reviewed in this second of two articles. New research on childhood and adolescent vaccines is anticipated to shape the practice of pediatric providers. Research will continue to provide the science to optimize protection and to promote the health and well being of all children and adolescents.
    Current opinion in pediatrics 08/2011; 23(4):470-81. DOI:10.1097/MOP.0b013e3283488160 · 2.53 Impact Factor
Show more